Clinical trial
A Prospective, Longitudinal, Observational, Multi-centre Study of Pediatric Participants up to 16 Years of Age With Methylmalonyl-CoA Mutase Deficiency Caused by Mutations in the MMUT Gene That Results in a Diagnosis of Isolated Methylmalonic Acidemia (MMA).
NCT07432880 is registered in ClinicalTrials.gov with Genespire Srl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Longitudinal, Observational, Multi-centre Study of Pediatric Participants up to 16 Years of Age With Methylmalonyl-CoA Mutase Deficiency Caused by Mutations in the MMUT Gene That Results in a Diagnosis of Isolated Methylmalonic Acidemia (MMA).
- Lead sponsor
- Genespire Srl
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 13, 2026
- Completion date
- August 31, 2030
- Enrollment
- 30 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
methylmalonic acidemia (mma)